Derma Sciences Inc. (DSCI) Swings to Q4 Profit
- Growth worries, rate hike uncertainty pull Wall Street down
- Yelp (YELP) Tops Q4 EPS by 14c, Offers Q1 Guidance, CFO Steps Down
- Are Gold Speculators Betting on 'One and Done'?
- Oil Companies Slash Dividends Amid Cash Crunch
- After-Hours Stock Movers 02/08: (SSNI) (MXL) (BSX) Higher; (GIG) (QLYS) (CMP) Lower (more...)
Derma Sciences Inc. (NASDAQ: DSCI) reports Q4 EPS of $0.01, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $13.65 million, compared to $12.56 million in Q408.
You May Also Be Interested In
- Alphabet (GOOG) (GOOGL) Price Targets Get Closer to a Googol Following Blowout Qtr
- Model N (MODN) Tops Q1 EPS by 1c; New CEO Named
- Compass Minerals (CMP) Tops Q4 EPS by 19c; Issues Light FY16 EPS Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!